MedPath

Clinical study of Chinese medicine combined with acupoint catgut embedding in treatment of obesity polycystic ovary syndrome

Phase 1
Recruiting
Conditions
Polycystic ovary syndrome
Registration Number
ITMCTR2022000057
Lead Sponsor
Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(l) It meets the two diagnostic criteria of polycystic ovary syndrome and obesity in western medicine.
(2) It conforms to the syndrome differentiation of traditional Chinese medicine and belongs to the syndrome type of kidney deficiency, liver heat, phlegm and blood stasis.
(3) Between the ages of 18 and 40.
(4) Volunteer subjects who can persist in treatment for 6 months.

Exclusion Criteria

(l) Patients with serious diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, psychosis.
(2) Other diseases that cause abnormal ovulation (Cushing's syndrome, atypical congenital adrenal hyperplasia, ovarian or adrenal tumors, functional hypothalamic amenorrhea, thyroid disease, hyperprolactinemia and early-onset ovarian insufficiency).
(3) Those who use hormonal and metabolic drugs at the same time to affect the result judgment.
(4) Those who are allergic to the study drug and cannot accept acupuncture stimulation.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
WHR;TCM symptoms;triglyceride;total cholesterol;Ovulation;BMI;Liver and kidney function;Low density lipoprotein;Menstrual condition;Ovarian condition;tongue and pulse pictures;Six items of sex hormones;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath